Profil bibliographique

Emma Bolam

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

13Publications signalées

10058Citations signalées

2Affiliations récentes

Institutions déclarées

Domaines associés

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesMalaria Research and ControlMosquito-borne diseases and controlImmunotherapy and Immune Responses

Publications récentes

Accès ouvert 2022 articleOpenAlex

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial

Daniel Jenkin, Adam Ritchie, Jeremy Aboagye, Sofiya Fedosyuk et autres

32 citationsThe Lancet Microbe

Accès ouvert 2022 articleOpenAlex

Production of a high purity, C‐tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions

Ekta Mukhopadhyay, Florian Brod, Philip Angell‐Manning, Nicola Green et autres

6 citationsBiotechnology and Bioengineering

Accès ouvert 2021 erratumOpenAlex

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Hannah Sharpe et autres

7 citationsNature Medicine

Accès ouvert 2021 erratumOpenAlex

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold, Katie Ewer et autres

13 citationsNature Medicine

Accès ouvert 2021 articleOpenAlex

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, Lily Yin Weckx et autres

1213 citationsThe Lancet

Accès ouvert 2020 articleOpenAlex

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Hannah Sharpe et autres

645 citationsNature Medicine

Accès ouvert 2020 articleOpenAlex

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold, Katie Ewer et autres

342 citationsNature Medicine

Accès ouvert 2020 articleOpenAlex

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, Lily Yin Weckx et autres

5034 citationsThe Lancet

Accès ouvert 2020 articleOpenAlex

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, Brian Angus et autres

2628 citationsThe Lancet

Accès ouvert 2018 articleOpenAlex

Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

Jing Jin, Richard Tarrant, Emma Bolam, Philip Angell‐Manning et autres

84 citationsnpj Vaccines

Accès ouvert 2010 articleOpenAlex

Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes

G Hale, Peppy Rebello, Ibrahim Al Bakir, Emma Bolam et autres

46 citationsThe Journal of Clinical Pharmacology

2006 book-chapterOpenAlex

Glutamine Synthetase Transfected Cells May Avoid Selection by Releasing Glutamine

Phillip I. Bird, Emma Bolam, L M Castell, Omar Obeid et autres

0 citationsKluwer Academic Publishers eBooks

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.